article
Revealing the genetic signature of neurodegenerative disease
Which immune cells contribute towards immune-induced neurodegeneration and how could this knowledge enable conditions such Alzheimer’s and multiple sclerosis to be treated?
List view / Grid view
Gladstone Institutes
Filter the results
news
Map of COVID-19 and human protein interactions reveals drug targets
Researchers have identified which SARS-CoV-2 proteins physically associate with proteins in human cells, revealing potential drug targets to treat the COVID-19 coronavirus.
news
Novel small molecule could treat Alzheimer’s disease and Dravet syndrome
A new experimental drug was shown by researchers to restore natural brain rhythms in mouse models of Alzheimer’s and promote learning and memory.
news
Machine learning programme used to predict stem cell growth
Researchers have used machine learning to predict the conditions needed for stem cells to develop a certain way, which could be used to grow 3D organ models.
news
Drug targets for Dengue, Zika and Ebola viruses
US researchers have identified possible drug targets for Dengue, Zika and Ebola viruses…
news
Immunotherapy targeting blood protein fibrin
Targeting the fibrin protein could ensure that fibrin leaking through the blood-brain barrier does not cause inflammation or disease in the brain...
news
Researchers create first stem cells using CRISPR genome activation
Researchers have turned skin cells from mice into stem cells by activating Sox2 and Oct4 using CRISPR technology...
news
Evotec, Gladstone Institutes and Dolby Family Ventures team up to find Alzheimer’s cure
24 July 2015 | By Victoria White
Evotec is teaming up with Cure Network Ventures and Dolby Family Ventures to identify new therapeutic approaches for Alzheimer’s disease...